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Polo-like kinase 1 (Plk1) has multiple important functions during M-phase progression. In addition to a catalytic domain,
Plk1 possesses a phosphopeptide-binding motif, the polo-box domain (PBD), which is required for proper localization.
Here, we have explored the importance of correct Plk1 subcellular targeting for its mitotic functions. We either displaced
endogenous Plk1 through overexpression of the PBD or introduced the catalytic domain of Plk1, lacking the PBD, into
Plk1-depleted cells. Both treatments resulted in remarkably similar phenotypes, which were distinct from the Plk1
depletion phenotype. Cells depleted of Plk1 mostly arrested with monoastral spindles, because of inhibition of centro-
some maturation and separation. In contrast, these functions were not impaired in cells with mislocalized Plk1. Instead,
these latter cells showed a checkpoint-dependent mitotic arrest characterized by impaired chromosome congression. Thus,
whereas chromosome congression requires localized Plk1 activity, other investigated Plk1 functions are less dependent on
correct PBD-mediated targeting. This opens the possibility that PBD-directed drugs might be developed to selectively
interfere with a subset of Plk1 functions.
INTRODUCTION
Reversible protein phosphorylation by protein kinases and
phosphatases plays a key role in the regulation of mitotic
progression (Nigg, 2001; Vagnarelli and Earnshaw, 2004).
Prominent among the mitotic kinases is Polo-like kinase 1
(Plk1) (Barr et al., 2004; Glover, 2005). Antibody microinjec-
tion and RNA interference (RNAi) studies have revealed
functions for human Plk1 in centrosome maturation and
spindle assembly (Lane and Nigg, 1996; Liu and Erikson,
2002; Sumara et al., 2004; van Vugt et al., 2004b). In the
absence of Plk1, cells do not form a bipolar spindle and
arrest in a prometaphase-like state with an activated mitotic
spindle checkpoint (Sumara et al., 2004; van Vugt et al.,
2004b). In addition, Plk1 has been implicated in chromatid
arm separation through cohesin removal, which in verte-
brate cells occurs during early mitosis (Sumara et al., 2002;
Gimenez-Abian et al., 2004; Hauf et al., 2005). Later during M
phase, Plk1 has been implicated in mitotic exit and cytoki-
nesis (Carmena et al., 1998; Descombes and Nigg, 1998;
Seong et al., 2002; Lindon and Pines, 2004; Lee et al., 2005).
Roles in other processes, notably responses and adaption to
DNA damage, have also been attributed to Polo kinases
(Toczyski et al., 1997; Smits et al., 2000; van Vugt et al., 2004a).
In line with this multitude of proposed functions, verte-
brate Plk1 localizes to diverse mitotic structures, including
centrosomes, kinetochores, and the central spindle and mid-
body (Golsteyn et al., 1995; Lee et al., 1995; Arnaud et al.,
1998; Barr et al., 2004). These localizations are mediated by
the noncatalytic C-terminal half of Plk1 (Seong et al., 2002).
This part of the kinase contains the so-called polo-box do-
main (PBD) that comprises two polo box motifs (Elia et al.,
2003a). These constitute specific signatures of the Polo-like
kinase family and have not been found in any other proteins.
Using a phosphopeptide-based proteomic screen, Yaffe and
coworkers discovered that the PBD constitutes a phos-
phopeptide-binding domain, which binds with maximal af-
finity to phosphopeptides containing a consensus sequence
S-pS/pT-P/X (Elia et al., 2003a). Similar interactions were
demonstrated for the PBDs of Polo kinases from other or-
ganisms as well as for the PBDs of human Plk2 and Plk3
(Elia et al., 2003b). Plk2 and Plk3 are structurally similar to
human Plk1 but believed to function in distinct cellular
processes (Barr et al., 2004).
Because the PBD of Plk1 interacted with a number of
proteins only when these were phosphorylated at specific
sites (Lowery et al., 2005), a model has been proposed ac-
cording to which the Plk1 PBD docks to particular target
proteins after phosphorylation by appropriate “priming”
kinases (Elia et al., 2003a). Crystallography studies have
confirmed specific binding of phosphopeptides to an inter-
face formed by the two polo-box repeats (Cheng et al., 2003;
Elia et al., 2003b). Two residues in human Plk1, His538 and
Lys540, interact directly with the phosphate group of the
peptide and are essential for phosphopeptide binding (Elia
et al., 2003b). In addition to its purported targeting function,
the PBD was also shown to interact with the catalytic do-
main of Plk1, resulting in a mutual inhibition of function, at
least in vitro (Jang et al., 2002a). Interestingly, this interaction
did not require a functional PBD phosphopeptide-binding
motif, indicating that the catalytic domain interacts with the
PBD through a different mechanism (Elia et al., 2003b). This
notwithstanding, phosphopeptide binding to the PBD re-
sults in kinase activation, suggesting that the induction of a
structural change liberates the catalytic domain from its
inhibitory interaction with the PBD (Elia et al., 2003b). Sim-
ilar to structurally related kinases, Plk1 activity is also reg-
ulated by phosphorylation of a residue (Thr210) within the
so-called activation loop (Jang et al., 2002b). This phosphor-
This article was published online ahead of print in MBC in Press
(http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–08–0801)
on November 2, 2005.
Address correspondence to: Herman H.W. Sillje´ (sillje@biochem.mpg.de).
Abbreviations used: PBD, polo-box domain.
448 © 2005 by The American Society for Cell Biology
ylation presumably stabilizes the activation loop in an open
conformation, and, in addition, it prevents the binding of the
PBD (Jang et al., 2002a). This may explain why the overex-
pression of PBD did not interfere with endogenous Plk1
kinase activity in vivo (Seong et al., 2002).
Ectopic expression of Plk1 in NIH 3T3 cells was reported
to cause malignant transformation and tumor growth in
nude mice (Smith et al., 1997). Moreover, aberrant expression
of human Plk1 in tissue culture cells caused defects in both
mitosis and cytokinesis (Mundt et al., 1997). Conceptually,
this might lead to aneuploidy, a hallmark of most human
tumors, and it is interesting, therefore, that many human
cancers show elevated levels of Plk1 (Eckerdt et al., 2005;
Takai et al., 2005). These observations suggest that Plk1
could constitute an attractive target for anticancer therapeu-
tics and a first small molecule inhibitor of Plk1 has recently
been described (Gumireddy et al., 2005). In this context, it is
interesting to consider that inhibition of Plk1 function might
be accomplished not only through targeting of the catalytic
domain but also through interference with the PBD (Lowery
et al., 2005).
In the present study, we have asked to what extent dif-
ferent Plk1 functions depend on PBD-mediated localization
of Plk1. Specifically, we have explored the consequences of
overexpression of PBD and compared the resulting mitotic
arrest phenotypes with those seen after RNAi-mediated de-
pletion of the kinase. We found that general catalytic activity
of Plk1 was sufficient to bring about centrosome maturation,
centrosome separation, and spindle assembly, but complete
chromosome congression and continued progression
through M phase were dependent on correctly localized
Plk1 activity. These findings have implications for both our
understanding of Plk1 function and the design of anti-Plk1
drugs.
MATERIALS AND METHODS
Cloning Procedures
The Plk1-PBDWT (aa 326–603) was cloned in-frame by PCR into a pcDNA3.1
vector encoding a amino-terminal 3xmyc-tag (Invitrogen, Carlsbad, CA) us-
ing primers 5-CCG GAA TTC CAG ATC TTC GAT TGC TCC CAG CAG
CCT GG-3 and 5-CCG CTC GAG TTA GGA GGC CTT GAG ACG GTT
GC-3. The myc-tagged Plk2-PBD (aa 355–685) and Plk3-PBD (aa 336–646)
constructs were PCR cloned in the same vector with the primers 5-GGC GGA
TCC CAC TTA TCA AGC CCA GCT AAG-3 and 5-GGC CTC GAG TCA
GTT ACA TCT TTG TAA GAG C-3 for PBD 2 and 5-GGC GGA TCC CCC
CCC AAC CCA GCT AGG AGT C-3 and 5-GGC CTC GAG CTA GGC TGG
GCT GCG GTC CCG G-3 for PBD3. The Plk1-PBDAA mutant (H538A,
K540A) was made by site-directed mutagenesis using the following primers:
5-CAA TTC TCC GGA GCC CCG CCT ATC TGT CCC-3 and 5-GGG ACA
GAT AGG CGG GGC TCC GGA GAA TTG-3.
For generating the stable cell lines, the myc-tagged Plk1-PBDWT and Plk1-
PBDAA gene fragments were introduced into the pcDNA4/TO vector (In-
vitrogen), in which the neomycin resistance marker had been replaced by a
puromycin cassette.
For rescue experiments, an established Plk1-RNAi targeting sequence
(Kraft et al., 2003) was cloned into the pTER vector (Brummelkamp et al.,
2002; van de Wetering et al., 2003). RNAi resistant myc-tagged Plk1 constructs
in the pcDNA3.1/3xmyc-C vector were generated by introducing six silent
point mutations in the RNAi targeting sequence using primers 5-TAA TGA
ACT TCT GAA CGA TGA GTT CTT TAC TTC TGG CTA TAT C-3 and
5-ACT CAT CGT TCA GAA GTT CAT TAA TGG TTG GGC GGG CAG TGG
G-3. The catalytically impaired Plk1 contains the a K82R replacement and the
Plk1 catalytic domain plasmid encodes amino acids 1–352. All PCR fragments
and mutations were checked by sequencing.
Cell Culture and Generation of Inducible Stable Cell Lines
HeLa S3 cells were grown at 37°C under 5% CO2 in DMEM (Invitrogen),
supplemented with 10% fetal calf serum and penicillin-streptomycin (100
IU/ml and 100 g/ml, respectively). For the generation of tetracycline-induc-
ible cell lines, the plasmids encoding myc-tagged Plk1-PBDWT and Plk1-
PBDAA, respectively, were transfected into a HeLa S3 cell line, which stably
expressed a tet repressor gene under control of the cytomegalovirus pro-
moter, together with a blasticidine resistance marker (pcDNA6/TR; Invitro-
gen). Stably transfected cell lines were established by selection with 5 g/ml
blasticidin and 1 g/ml puromycin. The expression of myc-PBDWT and
myc-PBDAA was induced by addition of 0.1 g/ml tetracycline.
Transient Transfections and RNAi
Plasmid transfections were performed using FuGENE6 reagent (Roche Diag-
nostics, Indianapolis, IN) according to the manufacturer’s instructions. Plk1,
Nuf2, and Mad2 were depleted using small interfering RNA (siRNA) duplex
oligonucleotides (Dharmacon Technologies, Lafayette, CO) targeting pub-
lished sequences (DeLuca et al., 2002; Martin-Lluesma et al., 2002; Kraft et al.,
2003). As a control, a duplex (GL2) targeting luciferase was used (Elbashir et
al., 2001). siRNA duplexes were transfected using Oligofectamine (Invitrogen)
as described previously (Elbashir et al., 2001). For rescue experiments, the
Plk1-RNAi plasmid (or the empty pTER vector as a control) was transfected
simultaneously with the respective myc-tagged Plk1 constructs (or myc-
hWW45 as a control), and cells were fixed and analyzed 40 h later.
Immunofluorescence Microscopy
Cells were grown on coverslips and either fixed and permeabilized in 20°C
methanol for 10 min or in 20 mM PIPES, pH 6.8, 4% formaldehyde, 0.2%
Triton X-100, 10 mM EGTA, and 1 mM MgCl2 for 10 min at room temperature.
Afterward cells were incubated for 30 min at room temperature in blocking
solution (phosphate-buffered saline [PBS], 1% bovine serum albumin). All
antibody incubations were carried out for 1 h at room temperature in a
humidified chamber, followed by three washes in PBS. Primary antibodies
used in this study were mouse monoclonal antibody (mAb) anti-myc (1:10;
9E10 tissue culture supernatant), mouse mAb anti--tubulin-fluorescein iso-
thiocyanate (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-
Plk1 (1 g/ml; Abcam, Cambridge, United Kingdom), human ANA and
CREST autoimmunsera (1:1000, Europa Bioproducts, Cambridge, United
Kingdom; and 1:5000, Immunovision, Springdale, AR, respectively), mouse
mAb anti--tubulin (1:1000, GTU-88; Sigma-Aldrich, St. Louis, MO), rabbit
anti-pericentrin (1:1000; Abcam), rabbit anti-centrin (1:600) and mouse mAb
anti-centrin (20H5, 1:5000; gift from J. L. Salisbury, Mayo Clinic College of
Medicine, Rochester, NY), mouse mAb anti-Aurora-A (1:1000; BD Biosciences
PharMingen, San Diego, CA), mouse mAb anti-Hec1 (1:1000; Abcam) and
rabbit anti-Mad2 serum (1:1000; Covance, Berkeley, CA). Primary antibodies
were detected with Alexa Fluor 488- and Alexa Fluor 555-conjugated goat
anti-mouse or anti-rabbit IgGs (1:1000; Invitrogen), respectively. DNA was
stained with 4,6-diamidino-2-phenylindole (DAPI; 2 g/ml). Immunofluo-
rescence microscopy was performed using a Zeiss Axioplan II microscope
(Carl Zeiss, Jena, Germany) with Apochromat 40 and 63 oil immersion
objectives, respectively. Photographs were taken using a Micromax charge-
coupled device (CCD) camera (model CCD-1300-Y; Princeton Instruments,
Trenton, NJ) and MetaView software (Visitron Systems, Puchheim, Ger-
many). For high-resolution images, a Deltavision microscope on a Nikon
Eclipse TE200 base (Applied Precision, Issaquah, WA) equipped with S Fluor
40/1.3 and Plan Apo 60/1.4 oil immersion objectives and a photometrics
CoolSnap HQ camera was used for collecting 0.15-m distanced optical
sections in the z-axis. Images at single focal planes were processed with a
deconvolution algorithm and then projected into one picture using the Soft-
worx software (Applied Precision). Images were cropped in Adobe Photo-
shop 6.0 and then sized and placed in figures using Adobe Illustrator 10
(Adobe Systems, Mountain View, CA).
Cell Extracts and Western Blot Analysis
Cells were washed once with ice-cold PBS containing 1 mM phenylmethyl-
sulfonyl fluoride, scraped off the plate, and resuspended in ice-cold HEPES
lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, and 0.5% Triton X-100)
containing 1 mM DTT, 30 g/ml RNase A, 30 g/ml DNase, protease, and
phosphatase inhibitors. After 15 min on ice, lysed cells were centrifuged at
13,000 rpm for 15 min at 4°C. Protein concentrations in the cleared lysate were
determined using the Dc protein assay (Bio-Rad, Hercules, CA), and equal
protein amounts were loaded on SDS-PAGE gels. Separated proteins were
transferred to nitrocellulose membranes (Whatman Schleicher and Schuell,
Keene, NH). For Western blot analysis, mouse mAb anti-Plk1 (1:10, PL2,
tissue culture supernatant), mouse mAb anti--tubulin (1:1000; Sigma-Al-
drich), and mouse mAb anti-myc (1:10, 9E10, tissue culture supernatant) were
used and detected by ECL Supersignal (Pierce Chemical, Rockford, IL) using
a digital Fujifilm LAS-1000 camera attached to an Intelligent darkbox II
(Raytest, Straubenhardt, Germany). For quantification of the signals, the
Advanced Data Image Analyzer imaging software was used (Raytest).
Mitotic Chromosome Spreads
HeLa S3 cells were either treated with Plk1 siRNA oligonucleotides for 36 h
or with nocodazole (100 ng/ml) overnight. The myc-PBDWT stable cell line
was induced for 24 h. Mitotic cells were collected by mitotic shake off,
centrifuged for 4 min at 1000 rpm, and resuspended in diluted DMEM culture
medium (40% DMEM without antibiotics and 60% deionized H2O). The cells
were allowed to swell at room temperature for 5 min before spinning and
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resuspending them in fixation solution (3:1 methanol/acetic acid). The fixed
cells were incubated at 4°C for at least 20 min, washed three more times with
the fixation solution, and finally, 10 l of each cell solution was dropped on
a 20°C HCl-treated coverslip that had been moistened before by breathing
on to it. After drying of the coverslip on a wet Kleenex tissue over a 60°C
heating block, spreads were stained for 5 min with 0.4 g/ml DAPI and
mounted.
In Vitro Phosphopeptide Binding
Recombinant GST, GST-PBDWT, and GST-PBDAA were purified from Esche-
richia coli using glutathione-Sepharose beads (GE Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom). These immobilized recombinant pro-
teins were incubated in HEPES binding buffer (25 mM HEPES, pH 7.4, 2 mM
EGTA, 2 mM MgCl2, 1 mM DTT, and 100 ng/ml okadaic acid) containing 75
M of the optimal PBD-binding phosphopeptide (Elia et al., 2003a). After
overnight incubation at 4°C, the beads were washed three times with binding
buffer, and bound peptides were subsequently eluted with 30% formic acid at
room temperature. The presence of phosphopeptides in these eluates was
then determined by matrix-assisted laser desorption ionization (MALDI)
mass spectrometry (MS).
RESULTS
An Intact Phosphopeptide-binding Motif Is Required for
Localization of the Plk1 PBD
To analyze the role of the Plk1 PBD in mitotic progression,
stable tetracycline-inducible cell lines were generated to ex-
press myc-tagged PBD wild-type (PBDWT) or a PBD mutant
(PBDAA) in which His538 and Lys540, two residues critical
for phosphopeptide binding, were changed to alanine resi-
dues. To verify the inability of this mutant to bind to phos-
phorylated residues, glutathione S-transferase (GST)-tagged
PBDWT and PBDAA were produced. In vitro binding studies
with these immobilized proteins showed that PBDWT, but
not PBDAA, readily interacted with the consensus PBD-bind-
ing phosphopeptide (PBDtide), as analyzed by mass spec-
trometry (Figure 1A), confirming finding of a previous study
(Elia et al., 2003b). The addition of tetracycline to the stable
cell lines induced the expression of both myc-PBDWT and
myc-PBDAA. After 24 h, the exogenous proteins reached10
times the level of endogenous Plk1, as quantified by Western
blot analysis using a Plk1 antibody that recognizes the PBD
(Figure 1B). Shorter induction times (8 h) yielded more
moderate myc-PBD expression levels, better suited for the
analysis of subcellular localization (Figure 1, B, C, and D).
The myc-tagged PBD proteins were visualized by staining
with anti-myc antibodies, and, simultaneously, the induced
cells were costained with antibodies against -tubulin, -tu-
bulin, and ANA autoimmune serum, markers for centro-
somes, microtubules, and kinetochores, respectively. The
Figure 1. Localization of the Plk1 PBD to
diverse spindle structures requires an intact
phosphopeptide-binding motif. (A) In vitro
analysis of phosphopeptide binding to GST-
PBDWT-, GST-PBDAA-, and control (GST)-
coated glutathione-Sepharose beads. Phos-
phopeptide binding was determined by MS.
Only with GST-PBDWT, a phosphopeptide
(PBDtide) of the correct m/z ratio, was de-
tected. (B) Expression analysis of Plk1 PBDWT
and PBDAA in stable cell lines induced with
tetracycline for the indicated time durations.
Equal amounts of cell lysates were probed
with anti-Plk1 antibody after Western blot-
ting. Endogenous Plk1 and the expressed
myc-tagged Plk1 PBDs are indicated. (C)
Myc-PBDWT and (D) myc-PBDAA stable cell
lines were induced for 8 h with tetracycline
and then fixed and permeabilized with form-
aldehyde/Triton X-100, or 20°C methanol
for -tubulin staining. Cells were analyzed
by indirect immunofluorescence microscopy
using anti-myc-tetramethylrhodamine B iso-
thiocyanate (red); DAPI (blue); and either
ANA autoimmune serum (green), anti--
tubulin (green), or anti--tubulin (green)
antibodies to reveal colocalization with ki-
netochores, centrosomes, and spindle micro-
tubules, respectively. Merged pictures are
shown at the right. Bars, 10 m.
A. Hanisch et al.
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PBDWT colocalized with kinetochores from prometa- to
metaphase, with centrosomes from pro- to anaphase, and
with the central spindle and the midbody during ana- and
telophase (Figure 1C). This localization is virtually identical
to that of endogenous Plk1 (Barr et al., 2004), confirming a
critical role of the PBD in the subcellular distribution of Plk1
(Seong et al., 2002). In case of the PBDAA mutant, no clear
staining of either kinetochores or the central spindle could
be observed in mitotic cells, and centrosome and midbody
staining were clearly reduced (Figure 1D). These results
suggest that Plk1 localization to the described structures is
mediated largely via PBD-dependent docking to phosphor-
ylated target proteins.
Overexpression of PBDWT Results in Displacement of
Endogenous Plk1 and Causes Mitotic Arrest
The short-term induction (8 h) of PBD expression described
above did not significantly change the cell cycle profile, but
longer induction times (24 h) resulted in a marked increase
in the mitotic index in cell populations expressing PBDWT,
but not PBDAA (Figure 2A, left). This increase in mitotic
index was quantitatively similar to that observed after Plk1
Figure 2. Overexpression of the Plk1 PBDWT
results in endogenous Plk1 displacement and
mitotic arrest. (A) Mitotic indexes of PBDWT
and PBDAA stable cell lines after treatment
for 24 h with (Tet) or without (Tet) tetra-
cycline (left graph). The mitotic indexes of
cells treated for 36 h with Plk1 and control
(GL2) siRNA duplexes are also shown (right
graph). The mitotic indexes were determined
by immunofluorescence microscopic analysis
of the stained DNA. Histograms show results
of three independent experiments (300–500
cells each), and bars indicate standard devi-
ations. (B) Mitotic indexes of cells transiently
transfected with myc-tagged PBDWT and the
PBDAA mutant form of Plk1 as well as the
wild-type PBDs of Plk2 and Plk3, respec-
tively. After 48 h of transient transfection,
cells were fixed and permeabilized with
formaldehyde/Triton X-100 and stained with
anti-myc antibody (9E10-tetramethylrhoda-
mine B isothiocyanate) and DAPI. The mi-
totic indexes of the transfected (myc-positive)
cells were then determined by immunofluo-
rescence microscopic analysis of the stained
DNA. Histograms show results of three in-
dependent experiments (200 cells each),
and bars indicate standard deviations. (C)
Immunofluorescence images of cells express-
ing the indicated myc-tagged Plk-PBD con-
structs. Cells were treated as described in B.
(D) PBDWT and PBDAA stable cell lines were
induced for 24 h with tetracycline and sub-
sequently fixed and permeabilized with
formaldehyde/Triton X-100. Cells were then
analyzed by indirect immunofluorescence
microscopy using an anti-Plk1 N-terminal
antibody (red), an anti--tubulin antibody
(green) and DAPI (blue). Bars, 10 m.
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depletion by appropriate siRNAs (Figure 2A, right), whereas
treatment of cells with a control (GL2) siRNA produced no
effect (Figure 2A). In transient transfection studies, PBDWT
also caused a mitotic arrest, whereas PBDAA was without
effect, confirming the results obtained with the inducible cell
lines (Figure 2B). Transient transfection was also used to
explore the consequences of overexpressing the PBDs of
Plk2 or Plk3. Neither one of these PBDs produced a signif-
icant mitotic arrest (Figure 2B), despite similar levels of
expression, as judged by immunofluorescence staining of
the individual transfected cells (Figure 2C). This indicates
that only the Plk1 PBDWT is able to compete effectively with
endogenous Plk1 protein for the binding to phosphorylated
docking proteins, despite similar phosphopeptide-binding
specificities of these PBDs in vitro (Elia et al., 2003b). There-
fore, additional sequences or structural motifs within the
docking proteins might further define PBD-binding specific-
ity in vivo.
To corroborate these results and confirm that the Plk1
PBD could displace endogenous Plk1 from its intracellular
binding partners, the localization of endogenous Plk1 was
examined by using an antibody directed against the N ter-
minus of Plk1. After expression of PBDAA for 24 h, endog-
enous Plk1 could readily be detected on centrosomes
and kinetochores (Figure 2D, top), but after expression of
PBDWT, this localization was clearly lost and only diffuse
staining could be observed (Figure 2D, bottom). Because
cells expressing PBDWT became arrested in a prometaphase
state (see below), we were unable to demonstrate the dis-
placement of endogenous Plk1 from the central spindle and
midbody. However, considering that Plk1 localization to
these structures depends on PBD-mediated binding to phos-
phorylated kinesin-6, MKlp2 (Neef et al., 2003), it seems
legitimate to assume that PBDWT overexpression would
most likely displace endogenous Plk1 also from the central
spindle and midbody. Together, the above-mentioned re-
sults suggest that PBDWT overexpression causes cells to
arrest in mitosis because excess PBD displaces endogenous
Plk1 from PBD-docking proteins and hence from its sites of
action.
PBDWT Expression Allows Bipolar Spindle Formation but
Causes Chromosome Congression Defects
To better understand the physiological importance of Plk1
localization, the phenotype of the mitotically arrested cells
produced by PBDWT overexpression was compared with
that observed upon siRNA-mediated depletion of Plk1. This
comparison revealed striking differences (Figure 3). In re-
sponse to Plk1 depletion,87% of the mitotic cells exhibited
spindles with monopolar or abnormally small bipolar mi-
crotubule arrays, centrosomes near each other, and chromo-
somes in a rosette-like arrangement (Figure 3A). Occasion-
ally, Plk1-depleted cells showed bipolar spindles of
apparently normal sizes, but these most often had unfo-
cused spindle poles; moreover, they lacked a centrosome at
one pole and instead contained the unseparated centrosome
pair on the opposing pole (Figure 3A, bottom row). In con-
trast to Plk1-depleted cells, 82% of the mitotic cells in-
duced to express PBDWT showed bipolar spindle formation
with properly separated centrosomes (Figure 3B). However,
although spindles appeared to be near-normal in these cells,
a clear metaphase plate was rarely observed and instead,
variable numbers of chromosomes failed to congress (Figure
3B). In summary, whereas Plk1-depleted cells mostly dis-
played unseparated centrosomes, monoastral spindles, and
chromosomes in a rosette-like arrangement, PBDWT-ex-
pressing cells formed bipolar spindles, but arrested with
chromosome congression defects.
To further analyze the chromosome congression defect
produced by PBDWT overexpression, we next examined the
kinetochore–microtubule attachments in these cells. In cells
arrested by PBDWT overexpression, the congressed chromo-
somes were clearly attached to kinetochore–microtubule
bundles, termed kinetochore-fibers (K-fibers), whereas the
uncongressed chromosomes did not show obvious K-fiber
attachment (Figure 4A). The kinetochore-attached microtu-
Figure 3. The mitotic phenotype of PBDWT-expressing cells is dis-
tinct from the phenotype of Plk1-depleted cells. (A) HeLa S3 cells
were treated with Plk1 siRNA duplexes for 36 h. After fixation and
permeabilization, cells were analyzed by indirect immunofluores-
cence microscopy using anti-pericentrin (red), anti--tubulin
(green) antibodies, and DAPI (blue) staining. (B) The myc-PBDWT
stable cell line was induced for 24 h with tetracycline. Cells were
fixed, stained, and analyzed as described in A. Bars, 10 m.
A. Hanisch et al.
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bules in PBDWT-expressing cells were cold stable (Figure
4B), suggesting that proper kinetochore–microtubule attach-
ments had occurred (Rieder, 1981). In contrast, kinetochore
microtubules of cells depleted of the kinetochore protein
Nuf2 were cold sensitive (Figure 4B), in agreement with
previous results (DeLuca et al., 2002). In addition, in PBDWT-
expressing cells the attached kinetochores were under ten-
sion, as indicated by measurements of the interkinetochore
distance, which was found to be 1.35  0.27 m, compared
with 1.58 0.44 m in control cells. In contrast, kinetochores
of uncongressed chromosomes showed interkinetochore
distances of only 0.73  0.14 m, which is similar to the
values for nocodazole-treated cells (0.72  0.14 m). This
indicates that microtubule-dependent pulling forces could
be generated in PBDWT-expressing cells. In agreement with
this conclusion, the spindle checkpoint protein Mad2, which
is known to localize to kinetochores that lack proper micro-
tubule attachment (Waters et al., 1998), could only be de-
tected, at variable levels, at kinetochores of uncongressed
chromosomes (Figure 4C). This is in striking contrast to
Plk1-depleted cells in which most, if not all, kinetochores
were strongly Mad2 positive, in agreement with previous
results (Figure 4C) (Sumara et al., 2004). In both cases,
though, the presence of Mad2 on at least some kinetochores
points to spindle checkpoint activation (Howell et al., 2000;
Shah and Cleveland, 2000). Indeed, the arrests induced by
either Plk1 depletion or PBDWT overexpression were spindle
checkpoint dependent, because in both cases Mad2 deple-
tion reduced the mitotic index by15-fold (our unpublished
data), confirming and extending previous results (Seong et
al., 2002; van Vugt et al., 2004b).
PBD Overexpression Does Not Interfere with Centrosome
Maturation
One of the first demonstrated roles for Plk1 in mammalian
cells relates to centrosome maturation during the G2-to-M
phase transition (Lane and Nigg, 1996). A hallmark of cen-
trosome maturation is the recruitment of -tubulin ring com-
plexes (TuRC) to the centrosomes, which is required for
increased microtubule nucleation at the onset of mitosis
(Khodjakov and Rieder, 1999; Palazzo et al., 2000). We there-
fore analyzed and compared -tubulin recruitment in Plk1-
depleted and PBD-overexpressing cells, using antibodies
against centrin as a centriolar marker (Paoletti et al., 1996). In
agreement with previous results, -tubulin recruitment was
impaired in the absence of Plk1, but, interestingly, it was not
significantly affected in cells expressing PBDWT (Figure 5A).
To further characterize this centrosome maturation defect,
we also analyzed two other proteins, pericentrin and Auro-
ra-A, which normally become enriched at mitotic centro-
somes. Pericentrin was recruited to almost normal levels in
both Plk1-depleted cells and PBDWT-expressing cells, argu-
ing that Plk1 depletion does not cause a general recruitment
defect (Figure 5B). Moreover, because pericentrin is one of
the proteins implicated in anchoring TuRCs to mitotic cen-
trosomes (Zimmerman et al., 2004), this also indicates that
the loss of -tubulin is not caused by the absence of this
anchoring protein.
Because Aurora-A kinase has also been implicated in cen-
trosome maturation (Hannak et al., 2001; Berdnik and
Knoblich, 2002), we also examined the fate of this protein.
Remarkably, in Plk1-depleted cells Aurora-A no longer lo-
calized to centrosomes, as visualized by costaining with
pericentrin, although it still localized to spindle microtu-
bules surrounding the centrosomes (Figure 5C). In PBD-
expressing cells, in contrast, Aurora-A localization to spin-
dle poles was not affected (Figure 5C). Thus, Plk1 depletion
Figure 4. Lack of proper kinetochore–microtubule attachments on
unaligned chromosomes in PBDWT-expressing cells. (A) Myc-
PBDWT induced cells were fixed and permeabilized with formalde-
hyde/Triton X-100 and then stained with anti--tubulin (green),
Hec1 (red), and DAPI (blue). A series of Z-stack images was taken
from a mitotic cell and subsequently deconvolved. The left panel (I)
shows a projection of the total Z-stack, whereas the middle (II) and
right panels (III) show separate Z-stacks of the same cell (bar, 10
m). Higher magnifications of the boxes indicated in II and III are
presented below (bar, 5 m). (B) The myc-PBDWT stable cell line
(middle row) was induced for 24 h with tetracycline and HeLa S3
cells (bottom panel) were treated with Nuf2 siRNA duplexes for
48 h. These cells, as well as control GL2-treated cells (top row), were
then incubated for 10 min on ice followed by fixation and perme-
abilization with formaldehyde/Triton X-100. Cells were analyzed
by indirect immunofluorescence microscopy using anti--tubulin
antibody (red), CREST autoimmune serum (green), and DAPI
(blue). (C) The myc-PBDWT stable cell line (top row) was induced for
24 h with tetracycline, and HeLa S3 cells (bottom row) were treated
with Plk1 siRNA duplexes for 36 h. After formaldehyde/Triton
X-100 fixation, cells were analyzed by indirect immunofluorescence
microscopy using anti-Mad2 antibody (red), ANA autoimmune
serum (green), and DAPI (blue) staining. Arrows indicate Mad2
positive kinetochores at uncongressed chromosomes. Bars, 10 m.
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impaired both the recruitment of -tubulin and Aurora-A to
the centrosome, whereas PBDWT overexpression did not
detectably interfere with centrosome maturation. Together,
these results show that both centrosome maturation and
separation are defective in Plk1-depleted cells, but not in
PBDWT-overexpressing cells.
Chromatid Arm Separation Occurs in PBD-expressing
Cells but Not in Plk1-depleted Cells
In vertebrate cells, Plk1 is required to remove the cohesin
complex from sister chromatid arms during early mitosis
(Sumara et al., 2002; Gimenez-Abian et al., 2004; Hauf et al.,
2005). In agreement with this conclusion, the analysis of
chromosome spreads showed that sister chromatid arms
remained closely paired in Plk1-depleted cells, but not in
nocodazole-arrested control cells (Figure 6). Interestingly,
sister chromatid arms were also separated in cells express-
ing PBDWT (Figure 6). This indicates that PBD overexpres-
sion, in contrast to Plk1 depletion, did not significantly
interfere with the removal of the cohesin complex from
chromosome arms.
The PBD Is Essential for Mitotic Progression
As shown above, the PBD-induced mitotic arrest phenotype
most likely results from the displacement of endogenous
Plk1 from its docking partners and sites of action (Figure
2D). The observation that, overall, the mitotic arrest pheno-
type produced by PBD overexpression was less severe than
the Plk1 depletion phenotype suggested that not all Plk1
functions were dependent to similar extent on the correct
localization of Plk1 activity. To test the hypothesis that some
Plk1 functions strictly required correct localization of Plk1,
whereas others could be performed even if Plk1 was dis-
placed, we attempted to rescue the Plk1 depletion pheno-
type by different Plk1 constructs. These rescue experiments
Figure 5. Centrosome maturation defects in
Plk1-depleted but not PBDWT-induced cells.
(A) The myc-PBDWT stable cell line (left) was
induced (Tet) for 24 h with tetracycline or
left untreated (Tet). HeLa S3 cells (right)
were either treated with Plk1 or control (GL2)
siRNA duplexes for 36 h. After 20°C meth-
anol fixation, cells were analyzed by indirect
immunofluorescence microscopy using anti-
-tubulin (green), anti-centrin antibodies
(red), and DAPI (blue) staining. (B) Same as
in A, but cells were analyzed after anti-peri-
centrin (red), anti-centrin (green), and DAPI
(blue) staining. (C) Same as in A, but cells
were fixed and permeabilized with formalde-
hyde/Triton X-100 and analyzed after anti-
Aurora-A (green) and anti-pericentrin (red),
and DAPI (blue) staining. Bars, 10 m.
Figure 6. Chromosome spreads display dissociated chromosome
arms in PBDWT-induced but not Plk1-depleted cells. Mitotic myc-
PBDWT cells were obtained by tetracycline induction of the stable
cell line for 24 h (left). HeLa S3 cells were either arrested in mitosis
by siRNA-mediated Plk1 depletion (middle) for 36 h or by nocoda-
zole treatment for 14 h (right). Mitotic chromosome spreads of all
cells were stained with DAPI. Bar, 10 m.
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involved cotransfection of an RNAi vector targeting Plk1
with an RNAi-resistant expression plasmid coding for wild-
type or mutant myc-tagged Plk1 proteins. Cotransfection of
the Plk1 RNAi vector with a plasmid coding for a myc-
tagged marker protein showed that 34% of all transfected
cells accumulated in mitosis (Figure 7A). Although less pro-
nounced, this phenotype is similar to that observed after
transfection of siRNA oligonucleotides (compare Figure 7A
with Figure 2A). Concomitant expression of myc-tagged
Plk1WT with the Plk1-specific RNAi vector drastically re-
duced the mitotic index, whereas a catalytically inactive
form of Plk1 (Plk1K82R) failed to rescue (Figure 7A). These
results confirm that Plk1 activity is required for progression
through mitosis. Most importantly, expression of the Plk1
catalytic domain (Plk1cat) was not sufficient to override the
mitotic arrest produced by the Plk1-specific RNAi vector
(Figure 7A). Because all myc-tagged Plk1 proteins were
expressed to similar levels (Figure 7B), these differences
cannot be attributed to different expression levels. These
results therefore clearly show that PBD-dependent targeting
of Plk1 is critical for mitotic progression.
The PBD Is Dispensable for Centrosome Maturation and
Separation, but Not for Chromosome Congression
To determine which, if any, of the defects apparent in the
Plk1-depleted cells could be rescued by expression of delo-
calized Plk1cat, we investigated the corresponding arrest
phenotype in more detail. This analysis revealed that Plk1cat
could indeed restore several of the Plk1-dependent pro-
cesses that were defective in Plk1-depleted cells. Whereas
proper centrosome separation and bipolar spindle formation
were impaired in Plk1-depleted cells (Figure 8A; our unpub-
lished data), in agreement with the data shown above (Fig-
ure 3A), these defects were no longer observed in depleted
cells expressing the Plk1cat domain (Figure 8A). Moreover,
both -tubulin and Aurora-A recruitment were clearly im-
paired in Plk1-depleted cells, but these defects could also be
rescued by expressing the Plk1cat domain (Figure 8B). These
experiments also confirmed that the catalytic domain alone
is not able to localize to centrosomes and kinetochores,
although some spindle-like staining could be observed (Fig-
ure 8, A and B). This is similar to the endogenous Plk1
localization in PBDWT-expressing cells (Figure 2D) and sug-
gests that Plk1 could interact in a PBD-independent manner
with microtubules. The most straightforward interpretation
of these data is that the PBD is essential for mitotic progres-
sion but not strictly required for centrosomal functions of
Plk1.
Despite recovery from the centrosome and spindle forma-
tion defects, cells expressing the catalytic domain still ar-
rested in mitosis, most likely because of chromosome con-
gression defects (Figure 8, A and B). Quantitative analysis of
the extent of chromosome congression revealed that in Plk1-
depleted cells most chromosomes were not congressed, as
expected for cells with monopolar spindles (Figure 8C, light
gray bars). In depleted cells expressing the Plk1 catalytic
domain, however, most cells showed partially congressed
chromosomes, very similar to the phenotype seen with cells
overexpressing the PBD (Figure 8C, dark gray and black
bars, respectively). These results therefore indicate that
proper chromosome alignment requires PBD dependent tar-
geting of Plk1 activity.
DISCUSSION
Human Plk1 plays several different roles during mitotic
progression, and it is thought that these functions require
precise targeting of Plk1 to particular subcellular structures
such as centrosomes and kinetochores (Barr et al., 2004). The
recent demonstration that the C-terminal PBD of Plk1 serves
as a phosphopeptide-binding domain has led to an attractive
model according to which the temporal and spatial control
of Plk1 action involves PBD-mediated targeting of the kinase
to phosphorylated docking proteins (Elia et al., 2003a,b).
Here, we have examined the importance of PBD-mediated
localization for different mitotic functions of Plk1. Specifi-
cally, we have analyzed the consequences of overexpressing
wild-type or mutant PBDs in HeLa S3 cells. We found that
PBDWT, but not PBDAA, localized to all known sites of Plk1
action (centrosomes, kinetochores, and the spindle mid-
zone). Moreover, prolonged expression of the PBDWT
caused a mitotic arrest, almost certainly because of the dis-
placement of endogenous Plk1 from PBD-docking proteins
and hence its sites of action. Most interestingly, this arrest
Figure 7. Expression of only the Plk1 catalytic domain in a Plk1-
depleted background is not sufficient to overcome mitotic arrest. (A)
HeLa S3 cells were cotransfected for 40 h with an empty RNAi
vector () or an insert targeting Plk1, together with protein expres-
sion vectors (Rescue) coding for different myc-tagged Plk1 con-
structs or a myc-tagged control protein, as indicated. Cells were
fixed and permeabilized with formaldehyde/Triton X-100 and were
stained with anti-pericentrin antibody, anti-myc 9E10 antibody, and
DAPI. The mitotic indexes were determined as in Figure 2B. Histo-
gram shows the results of three independent experiments (300–500
cells each), and bars indicate standard deviations. (B) Expression
levels of the different myc-tagged Plk1 proteins (Rescue) were ana-
lyzed by Western blotting using the anti-myc 9E10 antibody, and
detection of -tubulin was used as a loading control.
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Figure 8. The PBD is dispensable for centrosome maturation and separation but required for chromosome congression. (A) HeLa S3 cells
were cotransfected for 40 h with a Plk1-targeting RNAi vector and plasmids coding for either a myc-control protein or the myc-Plk1 catalytic
domain. Cells were fixed and permeabilized with formaldehyde/Triton X-100 and then stained with anti-myc 9E10 antibody, DAPI, and
anti-pericentrin antibody to visualize centrosome separation. Histogram shows the quantification of cells with separated centrosomes.
Centrosomes were regarded as separated if they were positioned at opposite sites of the chromosome masses. Results are of three
independent experiments (100 cells each), and bars indicate standard deviations. (B) Same as in A, but cells were either fixed
A. Hanisch et al.
Molecular Biology of the Cell456
phenotype was clearly distinct from that seen in Plk1-
depleted cells (Table 1). This suggests that proper Plk1 lo-
calization is critical for some, but not all, mitotic functions of
Plk1. In support of this conclusion, we could demonstrate
that overexpression of the Plk1 catalytic domain in a Plk1-
depleted background resulted in a phenotype very similar to
that seen in PBD-overexpressing cells (Table 1). This rescue
experiment confirms that sufficient amounts of delocalized
Plk1 activity can perform centrosome maturation, separa-
tion, and spindle formation, but not proper chromosome
congression. From the perspective of therapeutic approaches
aimed at inhibiting Plk1 activity, this observation opens the
interesting possibility that drugs targeting the PBD could be
tailored such as to interfere only with a subset of Plk1
functions.
Both PBD overexpression and Plk1 depletion resulted in a
spindle checkpoint-dependent mitotic arrest, but the pheno-
types of the arrested cells were strikingly different. In con-
trast to Plk1 depletion, PBD overexpression did not signifi-
cantly impair centrosome maturation and separation, loss of
sister chromatid arm cohesion, and bipolar spindle forma-
tion. Instead, PBD overexpression did interfere with chro-
mosome congression. At first sight, one could argue that this
defect might reflect direct inhibition of endogenous Plk1 by
PBD. However, this interpretation is unlikely, for the follow-
ing reasons. First, PBD overexpression was previously
shown not to affect the bulk activity of endogenous Plk1
(Seong et al., 2002). Second, the critical chromosome congres-
sion defect was observed only in cells expressing PBDWT but
not in cells expressing a PBDAA mutant. Considering that
both wild-type and mutant PBDs are able to interact with
the catalytic domain of Plk1 (Elia et al., 2003b), a direct
inhibitory interaction of the PBD with endogenous Plk1
seems unlikely. Thus, the most straightforward interpreta-
tion of our results is that PBDWT, but not PBDAA, competes
with endogenous Plk1 for the binding to phosphorylated
docking proteins. This conclusion is strongly supported by
our observation that endogenous Plk1 could be displaced
from centrosomes and kinetochores by PBDWT but not
PBDAA. Furthermore, our rescue experiments showed that
Plk1-depleted cells expressing only the catalytic domain of
Plk1 displayed a mitotic phenotype very similar to that
seen in PBDWT-overexpressing cells. Thus, although de-
localized Plk1 activity seems to be sufficient for some Plk1
functions, it cannot provide all functions required for
mitotic progression.
In agreement with previous results (Lane and Nigg, 1996;
Sumara et al., 2004; van Vugt et al., 2004b), our study con-
firms that Plk1 is required for -tubulin recruitment during
centrosome maturation. In addition, we discovered that the
centrosomal recruitment of Aurora-A, a kinase also impli-
cated in centrosome maturation and bipolar spindle forma-
tion (Nigg, 2001), was abolished in the absence of Plk1. In
contrast, Aurora-A localization to spindle microtubules was
not affected. These results clearly demonstrate that Plk1
regulates Aurora-A recruitment to the centrosome. Regard-
less of whether this Plk1 requirement reflects a direct or
indirect mechanism, this observation suggests that Plk1 acts
upstream of Aurora-A in centrosome maturation and spin-
dle formation.
Because endogenous Plk1 prominently localizes to centro-
somes, it may seem surprising that PBD-mediated displace-
ment of Plk1 did not interfere with centrosome maturation
and separation. It is difficult to rigorously exclude that very
low levels of Plk1 might have remained at centrosomes in
PBDWT-expressing cells, and although undetectable by im-
munofluorescence microscopy, might have been sufficient to
carry out the analyzed centrosome functions. However, the
fact that overexpression of the catalytic domain in Plk1-
depleted cells was sufficient to restore centrosome matura-
tion and spindle assembly would argue that localized Plk1
activity is not absolutely required for the analyzed centro-
some functions. In contrast, the catalytic domain alone was
unable to restore sufficient chromosome congression to sat-
isfy the spindle checkpoint, so that Plk1-depleted cells ex-
pressing only delocalized activity arrested with a phenotype
closely resembling that seen in PBD-overexpressing cells.
These results thus indicate that the investigated centrosomal
functions of Plk1 are less dependent on localized Plk1 activ-
ity than the chromosome congression function.
Although suggested previously (Seong et al., 2002), a role
of Plk1 in chromosome congression has not attracted atten-
tion, most likely because chromosome congression is diffi-
Figure 8 (facing page). and permeabilized with 20°C methanol
and stained with anti-myc 9E10 antibody, anti--tubulin antibody,
and DAPI (top) or fixed and permeabilized with formaldehyde/
Triton X-100 and stained with anti-myc 9E10 antibody, anti-Auro-
ra-A antibody and DAPI (bottom). Histograms show the quantifi-
cation of the recruitment of -tubulin and Aurora-A, respectively.
Results are of three independent experiments (50 cells each), and
bars indicate standard deviations. (C). Histogram shows quantifi-
cation of the different degrees of chromosome congression to the
metaphase plate in PBDWT-expressing cells (black bars), in cells
expressing the Plk1 catalytic domain in a Plk1-depleted background
(dark gray bars), and in Plk1-depleted cells (light gray bars). The
term “partial congression” is used to describe cells in which a
metaphase-like plate is present together with variable numbers of
uncongressed chromosomes, whereas “no congression” describes
cells that do not show an obvious metaphase plate. Results are of
three independent experiments (100 cells each), and bars indicate
standard deviations. Bars, 10 m.
Table 1. Comparison of the different mitotic defects
Control PBDWT Plk1 depletion Plk1 depletion  catalytic domain
Centrosome maturation:
-Tubulin recruitment    
Aurora-A recruitment    
Centrosome separation    
Spindle formation    
Chromosome congression    
Loss of arm cohesion    Nda
a Because of technical limitations, this defect could not be determined in these transiently transfected cells.
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cult to study in Plk1-depleted cells, which arrest mostly with
monoastral spindles. The exact nature of the chromosome
congression defect in cells harboring only delocalized Plk1
activity remains to be determined, but our observation that
nonaligned chromosomes were not attached to K-fibers in
PBD-overexpressing cells suggests that microtubule capture
or maintenance of kinetochore–microtubule attachments de-
pends on localized Plk1 activity. Plk1 has long been known
to localize to kinetochores (Arnaud et al., 1998), and with the
identification of a PBD-dependent role of Plk1 in chromo-
some congression this strongly points to a critical function at
this site. In future studies, it will thus be important to
identify Plk1 PBD-interacting proteins among kinetochore
components and to study their involvement in chromosome
congression.
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